Michael M. Goldberg, Director at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), bought 100,000 shares at $1.06 ($108K) on 2014-11-13, disclosed to the SEC on 2014-11-17.
Open-market purchase of $108k NAVB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.06 | 71,641 | $76K | 70.5% |
| 2 | $1.12 | 28,359 | $32K | 29.5% |
| Total | $1.08 avg | 100,000 | $108K | 100% |